JP2011509936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509936A5 JP2011509936A5 JP2010542367A JP2010542367A JP2011509936A5 JP 2011509936 A5 JP2011509936 A5 JP 2011509936A5 JP 2010542367 A JP2010542367 A JP 2010542367A JP 2010542367 A JP2010542367 A JP 2010542367A JP 2011509936 A5 JP2011509936 A5 JP 2011509936A5
- Authority
- JP
- Japan
- Prior art keywords
- drug product
- formulation
- chamber
- fine particle
- particle fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940126534 drug product Drugs 0.000 claims description 50
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 50
- 238000009472 formulation Methods 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 37
- 239000010419 fine particle Substances 0.000 claims description 27
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 13
- 229940071648 metered dose inhaler Drugs 0.000 claims description 13
- 229960002744 mometasone furoate Drugs 0.000 claims description 13
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims description 13
- OBRNDARFFFHCGE-PERKLWIXSA-N (S,S)-formoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-PERKLWIXSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 229960000193 formoterol fumarate Drugs 0.000 claims description 12
- 239000003380 propellant Substances 0.000 claims description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 5
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000005642 Oleic acid Substances 0.000 claims description 5
- 229960004756 ethanol Drugs 0.000 claims description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
- 229960002969 oleic acid Drugs 0.000 claims description 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 3
- 208000006673 asthma Diseases 0.000 claims description 3
- UKACHOXRXFQJFN-UHFFFAOYSA-N heptafluoropropane Chemical compound FC(F)C(F)(F)C(F)(F)F UKACHOXRXFQJFN-UHFFFAOYSA-N 0.000 claims description 2
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 1
- 229960002848 formoterol Drugs 0.000 claims 1
- 239000012735 once-a-day formulation Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 10
- 239000013066 combination product Substances 0.000 description 1
- 229940127555 combination product Drugs 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229940127212 long-acting beta 2 agonist Drugs 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2033308P | 2008-01-10 | 2008-01-10 | |
| PCT/US2009/030562 WO2009089422A2 (en) | 2008-01-10 | 2009-01-09 | Inhalation drug products, systems and uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509936A JP2011509936A (ja) | 2011-03-31 |
| JP2011509936A5 true JP2011509936A5 (OSRAM) | 2012-12-06 |
Family
ID=40514046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010542367A Withdrawn JP2011509936A (ja) | 2008-01-10 | 2009-01-09 | 吸入薬物製品、システムおよび使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110182830A1 (OSRAM) |
| EP (1) | EP2244692A2 (OSRAM) |
| JP (1) | JP2011509936A (OSRAM) |
| CA (1) | CA2711292A1 (OSRAM) |
| MX (1) | MX2010007569A (OSRAM) |
| WO (1) | WO2009089422A2 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201113662D0 (en) * | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
| CN115813935A (zh) * | 2021-09-16 | 2023-03-21 | 上海上药信谊药厂有限公司 | 药物组合物、气雾剂及其制备方法和气雾剂产生系统 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI324934B (en) * | 2001-08-28 | 2010-05-21 | Schering Corp | Pharmaceutical compositions for the treatment of asthma |
| US20080210225A1 (en) * | 2007-03-01 | 2008-09-04 | Rapha Institute For Health | Disposable antistatic spacer |
-
2009
- 2009-01-09 US US12/812,287 patent/US20110182830A1/en not_active Abandoned
- 2009-01-09 EP EP09701184A patent/EP2244692A2/en not_active Withdrawn
- 2009-01-09 WO PCT/US2009/030562 patent/WO2009089422A2/en not_active Ceased
- 2009-01-09 JP JP2010542367A patent/JP2011509936A/ja not_active Withdrawn
- 2009-01-09 MX MX2010007569A patent/MX2010007569A/es not_active Application Discontinuation
- 2009-01-09 CA CA2711292A patent/CA2711292A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brunaugh et al. | Formulation techniques for high dose dry powders | |
| TWI229601B (en) | Combinations of a beta-2 agonist and a steroid | |
| JP2012082229A (ja) | 抗コリン作用薬、コルチコステロイドおよび長時間作用性βアゴニストを合わせる薬物および方法 | |
| EP1531866A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| CN1341017A (zh) | 用于治疗气喘的福莫特罗和糖酸莫米松的组合 | |
| CN107998109A (zh) | 药物组合物 | |
| JP2010539182A (ja) | 治療剤の新規組み合わせ | |
| JP2016519160A (ja) | ３つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム | |
| JP2015519356A5 (OSRAM) | ||
| KR101668203B1 (ko) | 천식의 병세악화를 예방 및/또는 치료하기 위한 포르모테롤 및 베클로메타손 디프로피오네이트를 포함하는 조성의 용도 | |
| Rawal et al. | Dry-powder inhaler formulation of rifampicin: an improved targeted delivery system for alveolar tuberculosis | |
| CN106470700A (zh) | 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合 | |
| KR101475262B1 (ko) | 천식 치료에 사용되는 흡입용 복합 조성물 | |
| CN102458372A (zh) | 适用在干粉吸入器中的聚结物制剂 | |
| US20040258626A1 (en) | Inhalation compositions | |
| US20130104881A1 (en) | Stabilized Metered Dose Inhaler | |
| CN107106516A (zh) | 药物组合产品 | |
| WO2010146394A1 (en) | Theobromine for the treatment of cough | |
| JP2011509936A5 (OSRAM) | ||
| CN116963715A (zh) | 茚达特罗的液体配制品 | |
| CN119584966A (zh) | 茚达特罗和格隆铵的液体配制品 | |
| CN118903435A (zh) | 复方药物制剂及其在医药上的应用 | |
| Taylor et al. | Next Generation Formulations for pMDIs | |
| Morley et al. | Development of a novel powder formulation for treatment of idiopathic pulmonary fibrosis | |
| CN110664819A (zh) | 供吸入的齐墩果酸制剂及其制备方法与医药用途 |